CompletedPhase 4

Scalp Nerve Block and Opioid Consumption in Brain Surgery

Thailand100 participantsStarted 2013-03

Plain-language summary

Anterior scalp block with 0.5% plain Marcaine 20 ml. may reduce the intraoperative opioid consumption in neurosurgical patients who undergoing the supratentorial craniotomy compared to those who receive 0.9% normal saline solution (placebo).

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients who have supratentorial brain tumor
✓. Patients have been scheduled to undergo an elective craniotomy to remove tumor in any surgical position
✓. Patients have been general anesthetized with endotracheal intubation and control ventilation
✓. Patients who have provided consent for the participation in the research and for the use of their medical record in research

Exclusion criteria

✕. Pregnant patients
✕. Patients who have a history of local anesthetic allergy and/ or anaphylaxis

What they're measuring

Intraoperative opioid consumption

Timeframe: During the supratentorial craniotomy surgery

Trial details

NCT IDNCT02057367

SponsorChiang Mai University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2016-02

View on ClinicalTrials.gov More Brain Tumour trials